IRIS
CICERI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.956
NA - Nord America 4.144
AS - Asia 2.481
SA - Sud America 60
OC - Oceania 31
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.104
SE - Svezia 2.184
SG - Singapore 1.225
IT - Italia 1.184
CN - Cina 882
RU - Federazione Russa 874
FI - Finlandia 165
DE - Germania 135
IE - Irlanda 125
IN - India 115
NL - Olanda 93
GB - Regno Unito 66
JP - Giappone 66
BR - Brasile 53
CA - Canada 33
HK - Hong Kong 31
FR - Francia 29
AU - Australia 24
IR - Iran 24
PK - Pakistan 22
TR - Turchia 21
AT - Austria 19
IL - Israele 16
SA - Arabia Saudita 15
ES - Italia 14
ID - Indonesia 12
KR - Corea 12
ET - Etiopia 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
DK - Danimarca 7
NZ - Nuova Zelanda 7
RO - Romania 7
TH - Thailandia 7
UA - Ucraina 6
AR - Argentina 5
BY - Bielorussia 5
DZ - Algeria 5
EG - Egitto 5
MX - Messico 5
NO - Norvegia 5
PL - Polonia 5
TW - Taiwan 5
BG - Bulgaria 4
PH - Filippine 4
BE - Belgio 3
CH - Svizzera 3
IQ - Iraq 3
LT - Lituania 3
MA - Marocco 3
PT - Portogallo 3
BD - Bangladesh 2
DO - Repubblica Dominicana 2
EU - Europa 2
HU - Ungheria 2
MK - Macedonia 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
VN - Vietnam 2
BH - Bahrain 1
EE - Estonia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
SI - Slovenia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 11.699
Salva come PNG Salva come JPEG
Città #
Lawrence 812
Princeton 811
Singapore 772
Ashburn 476
Milan 392
Shanghai 380
Moscow 343
New York 337
Boardman 132
Helsinki 129
Dublin 120
Rome 97
Washington 83
Dallas 70
Castelseprio 61
Los Angeles 60
Pune 59
Guangzhou 54
Seattle 50
Lappeenranta 35
Beijing 32
Chandler 29
Shenzhen 26
Dronten 23
Bologna 22
Hong Kong 21
Campos do Jordao 18
Genoa 17
Hanover 17
Turin 17
Jiaxing 16
São Paulo 16
London 15
Santa Clara 15
St Petersburg 15
Monza 14
Borås 13
Amsterdam 12
Brescia 12
Munich 12
Tokyo 12
Clifton 11
Meppel 10
Pisa 10
Toronto 10
Verona 10
Wuxi 10
Boston 9
Florence 9
Gatchina 9
Vienna 9
Aksum 8
Ankara 8
Bergamo 8
Cambridge 8
Hyderabad 8
Kassel 8
Naples 8
San Jose 8
Shijiazhuang 8
Ancona 7
Bangkok 7
Chicago 7
Elmendorf 7
Hangzhou 7
Jakarta 7
Lahore 7
Multan 7
Nuremberg 7
Paris 7
Philadelphia 7
Redwood City 7
Xi'an 7
Andover 6
Chennai 6
Council Bluffs 6
Falls Church 6
Livorno 6
Mountain View 6
Perm 6
Prague 6
Rockville 6
Segrate 6
Brisbane 5
Dalmine 5
Delhi 5
Minsk 5
New Haven 5
Newark 5
Osimo 5
Overland Park 5
Padova 5
Palermo 5
Perth 5
Perugia 5
Quanzhou 5
Riyadh 5
Sharjah 5
Stockholm 5
Trieste 5
Totale 6.052
Salva come PNG Salva come JPEG
Nome #
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 218
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 110
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 76
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 65
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 61
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 59
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 56
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 51
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 49
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 49
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 49
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia 48
Raman spectroscopy for the assessment of acute myeloid leukemia: A proof of concept study 47
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 46
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 44
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 43
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 42
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 42
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 42
Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey 40
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 40
Loss of mismatched HLA in leukemia after stem-cell transplantation 39
Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients 38
MicroCLOTS pathophysiology in COVID 19 38
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 36
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 36
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 35
Testosterone in males with COVID-19: A twelve-month cohort study 34
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 34
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 34
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 33
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 33
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 33
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 33
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 32
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 32
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 32
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 32
Chronic anticoagulant treatment and risk of mortality in SARS-Cov2 patients: a large population-based study 32
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 32
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 31
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients 31
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 31
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 30
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 30
After Action Reviews of COVID-19 response: Case study of a large tertiary care hospital in Italy 30
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 30
Integrated clinical role of echocardiography in patients with COVID-19 30
Biobanking for COVID-19 research 30
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 30
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 29
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura 29
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 29
Subclinical myocardial dysfunction in patients recovered from COVID-19 29
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 29
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 29
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT 28
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 28
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 28
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 28
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 28
RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study 28
COVID-19 mortality rate in nine high-income metropolitan regions 28
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 28
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 28
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 28
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies 28
Treosulfan-fludarabine-ATG-F based reduced-toxicity conditioning regimen: multicentre "Allo-Treo" study, results in 183 patients with haematological malignancies 27
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 27
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 27
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 26
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 26
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 26
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis 26
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide 26
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 26
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 26
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 26
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 26
One-year mental health outcomes in a cohort of COVID-19 survivors 26
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 26
Abrogation of GvHD and early immune reconstitution after infusion of HSV-TK engineered donor lymphocytes after haplo-identical hemopoietic stem cell transplantation. 25
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 25
High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome 25
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 25
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 25
PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS 25
Severely low testosterone in males with COVID-19: a case-control study 25
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 25
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study 24
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 24
FAS-based suicide gene strategy for controlled GvHD: An alternative to HSV-tk. 24
T cells for suicide gene therapy: Activation, functionality and clinical relevance 24
A new suicide system based on gene transfer of FAS into donor lymphocytes for controlled GVL. 24
A dual role for genetically modified lymphocytes in cancer immunotherapy 24
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 24
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 24
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19: Thromboembolism, diabetes and COVID-19 24
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 24
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 24
Totale 3.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 225.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 225.818
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 0 1 0 1 2 10 4
2020/2021234 6 5 17 68 16 51 20 8 25 1 13 4
2021/2022751 11 2 8 240 55 36 65 102 57 90 27 58
2022/20234.925 1.762 862 248 92 190 567 209 334 392 76 113 80
2023/20243.456 201 226 396 356 327 626 192 273 29 137 179 514
2024/20253.263 1.666 466 330 470 331 0 0 0 0 0 0 0
Totale 12.924